4.6 Article

In-hospital outcomes and long-term mortality according to sex and management strategy in acute myocardial infarction. Insights from the French ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2005 Registry

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 201, Issue -, Pages 265-270

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2015.08.065

Keywords

Acute myocardial infarction; Sex; Invasive strategy; Coronary angiography; Mortality

Funding

  1. Pfizer
  2. Servier
  3. Caisse Nationale d'Assurance Maladie-Travailleurs Salaries

Ask authors/readers for more resources

Background: The early mortality of acute myocardial infarction (AMI) has dramatically decreased in the recent past. Whether the previously reported sex disparities in use of invasive strategies (IS) persist and translate into differences in outcomes deserves to be examined. Methods: We used the data from a nationwide French prospective multicentre registry from 3,670 AMI patients (1155 women (31.5%), 2515 men (68.5%)) recruited in 223 centres in 2005 and followed-up for 5 years. We examined in-hospital outcomes and 5-year mortality in patients categorized according to sex and use of IS (i.e. coronary angiography during the hospitalisation with a view to revascularisation). Results: IS was less frequently used in women than in men (adjusted OR = 0.66; 95% CI: 0.52-0.85), regardless of the type of AMI, age group or risk category, while use of recommended medications was similar at 48 hours and discharge. In-hospital mortality did not differ according to sex, whatever the age group and use of an IS. At 5 years, overall and post-discharge mortality were similar in men and women. However, IS was associated with lower 5-year mortality in women (HR = 0.66; 95% CI: 0.510.86) as in men (HR = 0.48; 95% CI: 0.38-0.60) and there was no sex-strategy interaction. Conclusions: Invasive strategy remains less frequently used in women than in men, yet is associated with improved five-year survival irrespective of sex. Whether reducing the sex gap in its use would translate into a higher survival in women remains an open question. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses

Isabelle Durand-Zaleski, Gregory Ducrocq, Maroua Mimouni, Jerome Frenkiel, Cristina Avendano-Sola, Jose R. Gonzalez-Juanatey, Emile Ferrari, Gilles Lemesle, Etienne Puymirat, Laurence Berard, Marine Cachanado, Joan Albert Arnaiz, Manuel Martinez-Selles, Johanne Silvain, Albert Ariza-Sole, Gonzalo Calvo, Nicolas Danchin, Sandra Paco, Elodie Drouet, Helene Abergel, Alexandra Rousseau, Tabassome Simon, Philippe Gabriel Steg

Summary: This study assessed the cost-effectiveness and cost-utility ratios of restrictive vs. liberal transfusion strategy in acute myocardial infarction patients. The results showed that the restrictive strategy was dominant at 30 days, saving costs and improving outcomes, but it no longer maintained non-inferiority on MACE at 1 year.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Cardiac & Cardiovascular Systems

Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking

Michael Miller, Deepak L. Bhatt, Ph Gabriel Steg, Eliot A. Brinton, Terry A. Jacobson, Lixia Jiao, Jean-Claude Tardif, Christie M. Ballantyne, Matthew Budoff, R. Preston Mason

Summary: The study found that the use of IPE can reduce the risk of cardiovascular disease in smokers to the level observed in non-smokers.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

Article Cardiac & Cardiovascular Systems

External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry

Jeremie Abtan, Deepak L. Bhatt, Yedid Elbez, Gregory Ducrocq, Shinya Goto, Sidney C. Smith, E. Magnus Ohman, Kim A. Eagle, Kim Fox, Robert A. Harrington, Lawrence A. Leiter, Shamir R. Mehta, Tabassome Simon, Ivo Petrov, Peter R. Sinnaeve, Prem Pais, Eli Lev, Hector Bueno, Peter Wilson, Philippe Gabriel Steg

Summary: This study aimed to describe the proportion of eligible and ineligible patients for the THEMIS trial in a population with diabetes and stable coronary artery disease. 64.1% of patients did not meet THEMIS eligibility criteria, mainly due to prior myocardial infarction and use of oral anticoagulation. 28.1% of patients were eligible for the trial.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Article Pediatrics

Factors Predicting Statin Initiation During Childhood in Familial Hypercholesterolemia: Importance of Genetic Diagnosis

Noel Peretti, Alexandre Vimont, Emmanuel Mas, Jean Ferrieres, Patrick Tounian, Julie Lemale, Franck Boccara, Mathilde Di Filippo, Sybil Charriere, Philippe Moulin, Pierre Poinsot, Yves Cottin, Pierre-Henri Ducluzeau, Caroline Dourmap, Bertrand Cariou, Michel Farnier, Francois Paillard, Alain Pradignac, Cecile Yelnik, Antonio Gallo, Eric Bruckert, Sophie Beliard

Summary: Childhood and parental factors, including genetic diagnosis and parental vascular disease, are associated with the initiation of statin therapy in children with HeFH. Genetic diagnosis may be useful for cardiovascular prevention in children.

JOURNAL OF PEDIATRICS (2023)

Article Cardiac & Cardiovascular Systems

The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial

Andre Lamy, John Eikelboom, Wesley Tong, Fei Yuan, Shrikant Bangdiwala, Jackie Bosch, Stuart Connolly, Eva Lonn, Gilles R. Dagenais, Kelley R. H. Branch, Wei-Jhih Wang, Deepak L. Bhatt, Jeff Probstfield, Georg Ertl, Stefan Stoerk, P. Gabriel Steg, Victor Aboyans, Isabelle Durand-Zaleski, Lars Ryden, Salim Yusuf

Summary: The addition of rivaroxaban 2.5 mg BID to aspirin in patients with stable coronary artery disease or peripheral artery disease was found to reduce direct healthcare costs. In Canada, France, and Germany, the combination of rivaroxaban and aspirin was highly cost-effective in terms of lifetime cost-effectiveness.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Economics

Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France

Manon Belhassen, Olivier Hanon, Philippe Gabriel Steg, Isabelle Mahe, Melanie Nee, Flore Jacoud, Faustine Dalon, Francois-Emery Cotte, Dominique Guitard-Dehoux, Claire Marant-Micallef, Eric Van Ganse, Nicolas Danchin

Summary: This study compared the costs of healthcare resource use, stroke/systemic thromboembolism, and major bleedings between non-valvular atrial fibrillation patients who initiated apixaban and other oral anticoagulants. The results showed that patients initiating apixaban had lower costs in terms of healthcare resource use and event-related costs compared to other oral anticoagulants. Apixaban may be cost-saving compared to VKAs and cheaper than other DOACs, although the cost differences are limited.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2023)

Article Cardiac & Cardiovascular Systems

Clinical Significance of Culprit Vessel Occlusion in Patients With Non-ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention

Batric Popovic, Gregory Ducrocq, Yedid Elbez, Christoph Bode, Shamir. R. Mehta, Charles Pollack, Manel Sabate, Sunil Rao, Alexander Parkhomenko, Laurent J. Feldman, Neila Sayah, Marc S. Sabatine, Philippe Gabriel Steg

Summary: In patients with non-ST-elevation myocardial infarction (NSTEMI), total occlusion of the culprit coronary artery (OCA) is not uncommon. This study aimed to determine the frequency and clinical impact of OCA at presentation in a large population of patients with NSTEMI who underwent early invasive management. The results showed that patients with OCA had earlier coronary angiography, less involvement of the left anterior descending artery, higher prevalence of angiographic thrombus, higher mortality at 7 days, but similar mortality rates at 6 months.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Survival After Invasive or Conservative Management of Stable Coronary Disease

Judith S. Hochman, Rebecca Anthopolos, Harmony. R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O'Brien, Stavroula Mavromichalis, Michelle Chang, Aira Contreras, Yves Rosenberg, Ruth Kirby, Balram Bhargava, Roxy Senior, Ann Banfield, Shaun G. Goodman, Renato D. Lopes, Radoslaw Pracon, Jose Lopez-Sendon, Aldo Pietro Maggioni, Jonathan D. Newman, Jeffrey S. Berger, Mandeep S. Sidhu, Harvey D. White, Andrea B. Troxel, Robert A. Harrington, William E. Boden, Gregg W. Stone, Daniel B. Mark, John A. Spertus, David J. Maron

Summary: The ISCHEMIA trial compared the outcomes of initial invasive strategy versus initial conservative strategy in patients with chronic coronary disease and moderate or severe ischemia. The trial found no major difference in most outcomes, but there was lower risk of cardiovascular mortality and higher risk of noncardiovascular mortality with the invasive strategy.

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes

Emmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, Gregory Ducrocq, Ian Ford, Michal Tendera, Roberto Ferrari, Jean-Claude Tardif, Kim M. Fox, Philippe Gabriel Steg

Summary: This study compared the benefits of strict vs. standard control of blood pressure with the potential benefits of controlling other modifiable risk factors in patients with chronic coronary syndromes. The results showed that the benefit associated with strict blood pressure control was marginal and driven only by the diastolic component, while uncontrolled other risk factors were associated with a gradually increasing risk. Therefore, optimizing other risk factors should be prioritized over further reduction of systolic blood pressure. The optimal blood pressure target in chronic coronary syndromes may be <=139/79 mmHg.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention

Guillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, Steven L. Zelenkofske, A. Michael Lincoff, Roxana Mehran, P. Gabriel Steg, Christoph Bode, John H. Alexander, Thomas J. Povsic

Summary: This study compared the effectiveness of vascular closure devices (VCDs) with manual compression in reducing bleeding after transfemoral percutaneous coronary intervention. The results showed that there was no significant difference in bleeding rate between the two groups, but the VCD group had shorter recovery time. Further investigation is needed for high-bleeding risk populations.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Long-term follow-up of survivors of a first acute coronary syndrome: Results from the French MONICA registries from 2009 to 2017

Victoria Gauthier, Martin Lafrance, Mael Barthoulot, Louis Rousselet, Michele Montaye, Jean Ferrieres, Samantha Huo Yung Kai, Katia Biasch, Marie Moitry, Philippe Amouyel, Jean Dallongeville, Aline Meirhaeghe

Summary: The study aimed to characterize the long-term risk of first recurrence of ACS among survivors of an incident ACS, based on the STEMI/NSTEMI/UA diagnosis. The risk of recurrence did not depend on the type of the incident ACS, but major complications and impaired LVEF increased the risk. The most frequent forms of recurrence were NSTEMI and UA.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Article Health Care Sciences & Services

Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study

Jean Ferrieres, Eric Bruckert, Michel Farnier, Michel Krempf, Jean-Jacques Mourad, Baptiste Roux, Francois Schiele

Summary: This online survey studied French cardiologists' lipid-lowering approaches in patients with hypercholesterolemia and high cardiovascular risk. The results showed that most physicians underestimated the cardiovascular risk and selected higher-than-recommended LDL-C targets and less intensive treatment.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2023)

Editorial Material Cardiac & Cardiovascular Systems

Strategies to mitigate emergency department crowding and its impact on cardiovascular patients

Christopher W. Baugh, Yonathan Freund, Philippe Gabriel Steg, Richard Body, David J. Maron, Maame Yaa A. B. Yiadom

Summary: Emergency department (ED) crowding is a global problem caused by hospital capacity and other health system challenges. Patients with cardiovascular emergencies are particularly vulnerable due to the crowding, which may lead to avoidance of the ED, premature departure, or delays in receiving care. This paper discusses the causes of crowding, its impact on cardiovascular emergencies, and potential solutions.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Cardiac & Cardiovascular Systems

New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry

Alexandre Gautier, Fabien Picard, Gregory Ducrocq, Yedid Elbez, Kim M. Fox, Roberto Ferrari, Ian Ford, Jean-Claude Tardif, Michal Tendera, Philippe Gabriel Steg

Summary: This study found that new-onset atrial fibrillation (NOAF) is common among patients with chronic coronary syndromes (CCS) and is associated with increased risk of cardiovascular adverse events. Age, body mass index, glomerular filtration rate, ethnicity, alcohol intake, and left ventricular ejection fraction were identified as predictors of NOAF. The study suggests that more intensive preventive measures and systematic screening for atrial fibrillation should be considered in this patient population.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Early Development of Atherosclerotic Plaques in the Coronary Arteries after Radiotherapy for Breast Cancer (BACCARAT Study)

Manoj Kumar Honaryar, Rodrigue Allodji, Gaelle Jimenez, Mathieu Lapeyre, Loic Panh, Jeremy Camilleri, David Broggio, Jean Ferrieres, Florent De Vathaire, Sophie Jacob

Summary: This study aimed to evaluate the development of atherosclerotic plaques over 2 years after breast cancer radiotherapy (RT) and their associations with cardiac exposure. The results showed that the risk of overall plaque development was significantly associated with doses to the coronary arteries.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2023)

No Data Available